- Previous Close
6.25 - Open
6.20 - Bid 6.29 x --
- Ask 6.30 x --
- Day's Range
6.19 - 6.50 - 52 Week Range
4.03 - 6.91 - Volume
30,141,300 - Avg. Volume
35,494,731 - Market Cap (intraday)
10.792B - Beta (5Y Monthly) --
- PE Ratio (TTM)
89.86 - EPS (TTM)
0.07 - Earnings Date --
- Forward Dividend & Yield 0.01 (0.16%)
- Ex-Dividend Date Jul 18, 2024
- 1y Target Est
--
North China Pharmaceutical Company.Ltd engages in the research and development, production, and sales of pharmaceutical products in China. The company primarily offers anti-infective drugs; biotechnology drugs; cardiovascular cerebrovascular; immunomodulators; and vitamins and health products. It also provides chemical pharmaceuticals, biological agricultural and veterinary drugs. North China Pharmaceutical Company.Ltd was founded in 1992 and is based in Shijiazhuang, China.
www.ncpc.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 600812.SS
View MorePerformance Overview: 600812.SS
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 600812.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 600812.SS
View MoreValuation Measures
Market Cap
10.72B
Enterprise Value
20.51B
Trailing P/E
84.46
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.09
Price/Book (mrq)
1.99
Enterprise Value/Revenue
2.08
Enterprise Value/EBITDA
12.57
Financial Highlights
Profitability and Income Statement
Profit Margin
1.29%
Return on Assets (ttm)
2.15%
Return on Equity (ttm)
3.32%
Revenue (ttm)
9.87B
Net Income Avi to Common (ttm)
126.99M
Diluted EPS (ttm)
0.07
Balance Sheet and Cash Flow
Total Cash (mrq)
1.66B
Total Debt/Equity (mrq)
171.54%
Levered Free Cash Flow (ttm)
710.74M